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ABSTRACT1
Diagnostic methods based on single nucleotide polymorphism (SNP) biomarkers are2
essential for the real adoption of personalized medicine. Allele specific amplification in3
a homogeneous format or combined to microarray hybridization are powerful4
approaches for SNP genotyping. However, primers must be properly selected to5
minimize cross-reactivity, dimer formation and nonspecific hybridization. This study6
presents a design workflow diagram for the selection of required oligonucleotides for7
multiplex assays. Based on thermodynamic restrictions, the oligonucleotide sets are8
chosen for a specific amplification of wild- and mutant-type templates. Design9
constraints include the structural stability of primer-template duplexes, template-probe10
duplexes and self-annealing complexes or hairpins for each targeted gene. The11
performance of the design algorithm was evaluated for the simultaneous genotyping of12
three SNPs related to immunosuppressive drugs administered after solid organ13
transplantation. The assayed polymorphisms were rs1045642 (ABCB1 gene),14
rs1801133 (MTHFR gene) and rs776746 (CYP3A5 gene). Candidates were confirmed15
by discriminating homozygote and heterozygote populations using a fluorescence16
solution method and two colorimetric microarray methods on polycarbonate chips. The17
analysis of patient samples provided excellent genotyping results compared to those18
obtained by a reference method. The study demonstrates that the development of the19
allele-specific methods as pharmacogenetic tools can be simplified.20
21





Single nucleotide polymorphisms (SNPs) have been proposed as the next generation26
of markers to identify loci associated with complex diseases and their therapeutic27
treatment [1]. Technological tools and pharmagenomics principles that support28
personalized medicine are required to identify of effective drugs in advance (nature and29
doses), cut costs and improve patient quality of life. Unfortunately, the incorporation of30
genomic findings into health care systems is limited [2,3]. In particular, low-cost31
genotyping tools are absolutely necessary for effective personalized medicine.32
The allele-specific (AS) amplification of a particular nucleotide variant has a high33
potential to be developed for massive implementation into clinical laboratories [4]. The34
genotyping principle is based on an effective primer extension by the polymerase when35
the 3’ terminal base of the primer matches its target, whereas extension is inefficient or36
nonexistent when the terminal base is mismatched. AS-PCR methods are quick,37
excellent and inexpensive strategies which require minimal instruments that are found38
in most laboratories. The main limitation is the low-throughput capability (small number39
of SNP simultaneously analyzed). However, there are hundreds of pharmaceutical40
applications given the relatively few SNPs clinically validated for a given disease [5]. A41
simple AS-PCR approach is to use primer mixtures combined to genotyping42
determination based on product size or amplification kinetics [6-8]. Microarray43
hybridization-based methods show important additional advantages, such as cost-44
effectiveness and increased multiplexing [9,10]. The allele discrimination reaction is45
carried out in solution by multiplex allele-specific PCR and a solid phase array46
(conventional or zip-code format) displays the amplification results.47
AS-PCR methods involve up to five oligonucleotides per polymorphism. The48
oligonucleotide design is crucial in optimizing assays because a poorly selected primer49
or probe can result in little or no target product and, consequently, in erroneous50
discriminations. Many kinds of software tools are available for primer design for51
conventional PCR, including presence of a polymorphism in the input sequence or in52
primers [11-13]. Thanks to its capabilities and free accessibility, Primer3 Plus is the53
most popular non commercial primer design software [14]. In the genotyping field,54
some research teams have proposed tools and criteria for designing AS primers. The55
WASP tool is a primer design program applied specifically to AS-PCR [15]. However, a56
limited quantity of primers is provided, which might somewhat influence method57
performance. One remarkable program is BatchPrimer3, based on the Primer358
algorithm, which incorporates a specific module to choose the best primer pairs for AS-59
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amplification [16]. Nevertheless, these solutions were not developed to design60
hybridization probes or to include zip-codes.61
In the present study, a novel design workflow is developed for generating the62
oligonucleotides employed in SNP genotyping methods based on AS-amplification. The63
innovative algorithm supports the simplest approach (single reaction per variant) to the64
most complex alternative (combination of multiplex AS-PCR in solution and solid phase65
array in the zip-code format). The work includes the study of design variables, the66
experimental confirmation of in-silico parameters, and the determination of the67
analytical performances of the selected oligonucleotide sets.68
The design tool was applied to genotype the SNPs related to immunosuppressive69
drugs administered after organ transplantation (both initial and maintenance periods).70
Underexposure to calcineurin inhibitors, such as tacrolimus and cyclosporine, may71
result in acute rejection, while overexposure places patients at risk given its72
considerable toxicity. Nowadays, therapeutic drug monitoring helps determine suitable73
immunosuppressant dose adjustments per patient, but the work is usually done by an74
assay-error method. Several research studies have demonstrated that genetic factors75
(SNPs related in transport, metabolism and drug action) explain why patient groups76
respond differently to the administrated drug dose [17]. Therefore, their genotyping by77
simple diagnostic techniques will aid the fragile equilibrium there is between the risk78




Target polymorphism. Different SNPs have been described to be related in transport,82
metabolism and drug action, but the clinical community accepts only a few of them [18].83
The SNP catalogued as rs1045642 (C3435T polymorphism) is located in the ABCB184
gene, also known as the multidrug resistance gene. In organ transplantation, a lower85
immunosuppressor dose is required in those individuals who are TT homozygotes than86
CC homozygotes [19]. The rs776746 polymorphism (A698G) is located in the CYP3A587
gene, and the change of base produces a splicing defect that results in a nonfunctional88
cytochrome P450 protein found in the liver, small intestine and kidney. Homozygote89
AA, heterozygote AG and homozygote GG patients are normal, intermediate and slow90
metabolizers of immunosuppressants, respectively [20]. Another interesting91
polymorphism is rs1801133 (C677T), located in the MTHFR gene. Homozygote TT92
patients show diminished protein activity, which may lead to the risk of higher93
methotrexate toxicity [21]. As the prevalence of the TT genotype is high, these results94
may have implications for drug dosage.95
96
Oligonucleotide design tool. The nucleotide sequences for the studied97
polymorphisms were retrieved from the SNP database of the National Center for98
Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov). The multi-SNP99
program, supported in the Visual Basic language, was used to select oligonucleotides.100
The input data were the FASTA sequence of the gene regions, SNP alleles and design101
constraints. Alleles were indicated by IUPAC codes (G/C: S, A/T: W, G/A: R, T/C: Y,102
G/T: K, A/C: M). The design constraints and the program algorithm are described in103
Supplementary Material. The design output is the compatible primer sequences and104
amplification product sequences. Information is provided about oligonucleotides, such105
as size, melting temperature among others. The program also estimates the106
recommended annealing temperature under thermocycling conditions (in-silico PCR107
conditions). The expected value is calculated as Ta = Tm + ln L, where Tm is the lowest108
melting temperature of the primers and ln L the natural logarithm of PCR fragment109
length. The generation of candidate sets for organ transplantation110
pharmacogenenomics is also described.111
112
Reference design tools. Primer sets were also calculated from the Primer 3Plus113
software (http://www.bioinformatics.nl) and the WASP design tool114
(http://bioinfo.biotec.or.th/WASP). The primer constraints of the Primer 3Plus software115
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were 20 (18-27) mer, GC 20-80 %, melting temperature 60 ºC (57-63), product size116
110-175 bp, self-complementarity  8, 3'-complementarity  3. The primer constraints117
of WASP design tool were 20 mer (18-36), GC 50 % (20-85), melting temperature 60118
ºC (40-65), maximum temperature difference: 100, self-complementarity  8, 3'-119
complementarity  4, polyX in primer  3, product size 110-175 bp. The selected sets120
are listed in the Supplementary Material.121
122
Assays for checking designed oligonucleotides. Experiments were performed to123
test the selected oligonucleotide sets by considering three assay formats: single assay,124
multiplex assay based on common probe hybridization and multiplex assay based on125
universal hybridization.126
Single assay. Six amplification reactions (12.5 L) were performed per sample (two127
vials per SNP). Each reaction mixture contained 1×DNA polymerase buffer, 3 mM of128
MgCl2, 200 μM of each deoxynucleotide triphosphate, 20 μM of digoxigenin-11-2'-129
deoxyuridine 5'-triphosphate, 0.2 μM of forward primer (wild-type or mutant), 0.2 μM of130
reverse primer, 1 unit of DNA polymerase (Biotools, Madrid, Spain), and 4 ng of131
genomic DNA. To improve the differences between wild-type and mutant variants,132
locked nucleotide acids (LNA) were used as primers. Then the in-silico annealing133
temperatures reported by the developed program were corrected by considering this134
chemical modification. The cycling conditions were: initial denaturation at 95 °C for 5135
min followed by 38 cycles of denaturation at 95 °C for 30 s, primer annealing at 64 °C136
for 30 s, elongation at 72 °C for 30 s, and a final elongation at 72 °C for 5 min.137
Amplified DNA was quantified from the fluorescence measurements with a cyanine dye138
(SYBR-Safe, Invitrogen, Spain) at 0.01% (v/v) in a microtiter plate reader (Wallac,139
model Victor 1420 multilabel counter, Finland). Amplification yields were calculated in140
reference to the initial DNA (ng of amplified DNA/ng of initial DNA). Amplified products141
were also checked by electrophoresis on a 3% (w/v) agarose gel at 110 V and room142
temperature. Gels were stained for 30 min with 0.5× Tris/Borate/EDTA buffer that143
contained the fluorophore Real-Safe (Real Laboratories, Spain) at 0.01% (v/v). Bands144
were visualized with a UV transilluminator.145
Multiplex assay based on common probe hybridization. Raw polycarbonate slides were146
used as hybridization platforms. Each mixture of streptavidin (10 mg/L) and biotinylated147
probe (50 nM) in printing buffer (50 mM carbonate buffer, pH 9.6 and 1% glycerol (v/v))148
was transferred to the slide surface (50 nL) with a non contact printer (AD 1500 BioDot149
Inc., CA, USA). A tail of 10 thymines was appended to the probe at the 5’-end to150
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reduce surface interactions. Working temperature and relative humidity were controlled151
at 25 °C and 90%, respectively. The amount immobilized probe was about 0.03152
fmol/mm2. Amplification procedures were based on two triplex PCR reactions (12.5 μL),153
which contained the three WT-FPs (WT-vial) or the three M-FPs (M-vial), respectively.154
The composition of the reaction mixture and the cycling conditions were the same as in155
the single assay, except for primer concentrations (0.3 μM). Amplification products156
were purified by silica-gel membrane adsorption (PCR Purification Kit, Jena157
Bioscience) and eluted in low-salt buffer. The hybridization protocol on the158
polycarbonate slide and chip scanning was performed as described in Tortajada-159
Genaro et al. [10].160
Multiplex assay based on universal hybridization. A hexaplex PCR reaction (12.5 μL)161
that contained the zip-code FPs and RPs for the three studied SNPs was performed.162
The composition of the reaction mixture and the cycling conditions were as in the163
previous assay, except for the primer concentrations (0.3 μM). Amplification products164
were purified using silica-gel membranes prior to hybridization on the polycarbonate165
slide. The microarray layout consisted of 12 arrays of 8×6 dots each, with a 1-mm track166
pitch that corresponded to targeted genes, positive controls and negative controls167
(immobilization and hybridization). For hybridization, 2 µl of purified PCR product were168
mixed with 38 µl of hybridization solution, composed of SSC buffer 1 (sodium citrate169
15 mM, NaCl 150 mM, pH 7), 35% formamide, and 1.5 Denhardt’s reagent. The170
solution was denatured by heating at 95 °C for 5 min and transferred to the slide171
surface. Slides were incubated at 37 °C for 1 h in a conventional oven. Discs were172
gently washed for 1 min with diminishing dilutions of SSC (SSC 1, SSC 0.5, SSC173
0.05). Subsequently, the 1-mL mix of 1:2500 sheep antidigoxigenin-antibody (Abcam,174
Cambridge, UK) and 1:300 antisheep-antibody labeled with horse radish peroxidase175
(Abcam) in phosphate buffered saline solution, which contained 0.05 % detergent176
Tween-20 (PBST), was dispensed to the DVD and incubated for 30 min at room177
temperature in the dark. After washing with PBST and water, 1 ml of TMB (3,3′,5,5′-178
tetramethylbenzidine) was spread on the slide surface and incubated for 8 min at room179
temperature. The arrays were then washed with water. Chips were directly scanned180
(Epson Perfection 1640SU office scanner) to generate gray-scale images (Tagged181
Image File Format, color depth 16 bit, scale 0-65535). The optical intensity signals of182
each spot were quantified using in-house software for image analysis. Briefly, the183
spatial arrangement (or array addressing) was performed using a feature gridding184
reproducing the printing layout. Later, the image segmentation classified each pixel as185
foreground or as background using 250 m-circle masks. A quality control of image186
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was applied checking variability in pixel values within each spot mask and measuring187
circularity of spots. The spot intensity and the local background were calculated from188
the mean of pixel intensities within the spot and from the regions surrounding the spot,189
respectively. This image analysis was automatically performed in less than 2 min.190
191
Patient sample analysis. Thirty subjects (8 organ-transplantation patients and 22192
controls) were recruited for method optimization (n=10) and validation (n=20) according193
to ethics and with informed consent. Buccal swab and blood samples were collected.194
DNA extraction was performed using the PureLink Genomic DNA Mini Kit (Invitrogen),195
according to the manufacturer’s instructions. DNA concentration was determined using196
NanoDrop 2000/2000c (Thermo Scientific).197
For single assays, discrimination was based on the detection of either the fluorescence198
signal or the electrophoretic band. For the microarray formats, the genotype decision199
rule was constructed based on a discrimination index using the spot intensities of a200
wild-type probe (WT) and a mutant probe (MUT). Intensities were normalized from the201
corresponding average signals of the validation set. The expression of the202
discrimination index was (WTnormalized − MUTnormalized)/(WTnormalized + MUTnormalized) [10,22].203
This ratio is used to discriminate between a perfect and a mismatched target204
sequence, which differ by only one nucleotide (polymorphic nucleotide).205
Genotyping was also performed by means of reference techniques: MALDI-TOF by the206
MassArray platform (Sequenom) and Sanger sequencing by an ABI PRISM 3100207




The theoretical pairs of the forward primer (FP) and reverse primer (RPs) to be used in212
a single AS-PCR assay are tens or hundreds. The number of possible combinations in213
a multiplex assay (genotyping of several loci at time) can achieve thousands. Methods214
based on universal hybridization chips (primers containing a Zip-code region215
complementary to a specific probe) are a priori compatible with an extremely large216
number of oligonucleotide sets. However, the performances of method are sensitive to217
the selected set from the possible candidates. A workflow for the simultaneous218
genotyping of several SNPs was developed based on the choice of the oligonucleotide219
sets available to satisfactorily amplify/detect the given variants. Table 1 shows the220
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different steps of the selection process. The design activities per single SNP included221
the calculation of the candidate primer properties (e.g. position, length, hybridization222
and secondary structures) and product properties (e.g. secondary structures). These223
calculations were similar to those considered in the algorithms previously designed for224
conventional PCR primers [11,14].225
Specific design restrictions were incorporated by considering a multiplexed assay:226
similar melting temperatures of primers, absence of significant hybridization to the227
erroneous template, and variation in amplicon length. Melting calculations were made228
using available models and assumptions that describe the thermodynamic stability of229
DNA duplexes [23]. The sequence homology search and the measurement of their230
stability considering the ionic strength effect allowed cross-hybridization to be231
estimated. The objective was to effectively amplify all the targets by minimizing the risk232
of unbalanced amplification or cross-reactivity. Therefore, the design workflow233
eliminated the sets that did not fulfill restrictions. These restrictions have not been234
considered in previous algorithms for AS amplifications [12,15,16,24].235
For the automated generation of pre-candidate oligonucleotides and thermodynamic236
calculations, a computational program was developed in Visual Basic language237
(described as Supplementary Material). The program, called multi-SNP, selected the238
oligonucleotides for the simultaneous genotyping of up to 5 SNPs. Table 1 shows the239
relationship between the program modules and the task list based on design240
restrictions. The algorithm was designed to support methods based on individual or241
multiple allelic detections. The category of individual allelic methods includes end-point242
AS-PCR, single channel fluorescence qPCR, and most biosensing methods. The243
second category comprises methods based on multiple channel fluorescence qPCR244
and AS-PCR combined to capillary electrophoresis or DNA microarrays. If a specific245
module is activated, the output is useful universal microarray detection, including the246
zip-code for each primer and probe sequences for each targeted SNP.247
248
In-silico selection of oligonucleotide sets249
As proof of concept, the design algorithm was applied to support the administration of250
drugs related to organ transplantation. This pharmaceutical problem is an interesting251
example of applications that a low throughput genotyping method is required because252
the number of clinically relevant SNPs is low. Particularly, the target polymorphism253
were rs1045642, rs776746, and rs1801133. A discussion about the specific effect of254
design restrictions is included in the Supplementary Material file. Table 2 shows the255
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values selected for each restriction parameter according to the optimization protocol.256
Oligonucleotide sets were chosen to discriminate wild-type variants (C, C, and A257
alleles, respectively) and mutant variants (T, T, and G alleles, respectively) using258
different AS-PCR detection formats.259
The algorithm output for the conventional single approach (i.e. fluorescent detection of260
a specific genetic variant) was a list of the primer sets (wild-type FP, mutant-FP,261
common RP) selected for each targeted region. The candidate pairs of FP262
(direct/reverse strands) were 2/2, 2/8, and 0/2 and those of candidates RP were 33/27,263
24/47, and 47/39 for rs1045642, rs776746, and rs1801133. The computing results264
(direct/reverse strands) were the 66/54, 48/141, and 0/39 sets for rs1045642,265
rs776746, and rs1801133, respectively. The list of single assays is included as266
Supplementary Material (Table SI.1).267
For the multiplex assay, additional constraints collected in Multiplex module, were268
applied to these primer sets, such as cross-hybridization and product length269
differences. For direct strands, no set of rs1801133 was compatible. For reverse270
strands, the cross-annealing evaluation showed 28 sets had a primer that was271
theoretically hybridized with some templates of other genes (17 % of total cases). Of272
the 296,946 analyzed combinations, most sets were eliminated because the length273
differences between products were smaller than 10 bp (96 %). The output was a list of274
12,784 combinations (Table SI.2).275
The algorithm output for the advanced approach (Zip-code module) was a list of the276
primers, including zip-codes and corresponding probes. Zip-codes, also called tags,277
were sequences with no homology to either the target sequences or other sequences278
in the genome, which minimizes mismatch hybridizations. So primers contained the279
specific zip-code at the 5’ ends and the products hybridized to the specific zip-code280
probes were attached to the array. The algorithm evaluated possible combinations and281
eliminated the zip-codes for which template cross-annealing or zip-code-primer282
annealing was expected (melting temperature > 45 ºC). The selected flanking zip-283
codes were 16 of the 40 candidates (40 %). The list of sets is included in Table SI.3.284
Primer sets were also calculated from the Primer 3Plus software and the WASP design285
tool. The first is a general program applied for allele specific amplifications by fixing the286
FP. The second tool was specifically applied to select the allelic primers per287
polymorphism. In both cases, the primer pairs were individually designed to support288
methods that discriminate a single SNP per assay. Table 3 compares the289
performances of the programs used. The two previous programs are not prepared for290
multiple amplifications, nor for assays that use primers with zip-codes. The computed291
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sets are listed in Tables SI.4 and SI.5. Most oligonucleotides agreed with those292
obtained by the developed workflow. Discrepancies were related to minor differences in293
the thermodynamic calculations (i.e. reference melting temperature). Nevertheless,294
some sets were ruled out by the Multi-SNP program due to cross-hybridization295
between targeted genes.296
297
Checking the designed oligonucleotides for single assays298
Sets of primers selected by the developed workflow (Table SI.6) were tested by a299
conventional genotyping methods based on one reaction mixture per allele and SNP.300
The selected methods were end-point fluorescence measurement and agarose gel301
electrophoresis. In this approach, discrimination of allelic variants was optimized mainly302
by adjusting the thermocycling temperatures.303
The first AS-PCR experiments focused on confirming the best working temperatures304
that induced a selective perfect-match primer-template duplex. Wild-type and mutant305
templates were added to the reaction mixtures that contained the proposed sets and306
were amplified in an annealing temperature gradient (Figure 1). An erroneous307
amplification occurred at low annealing temperatures because both the forward primers308
hybridized and were extended. By increasing the temperature, a perfectly matched309
primer was more stable than a mismatched primer, and allele-specific amplification was310
preferentially produced. By applying a high temperature, the amplification yield lowered311
because a forward/reverse primer did not hybridize with target genes. A t-test was312
applied to establish the annealing temperature that produced a signal for the unspecific313
allele amplification comparable to the background signal. The selected annealing314
temperature was 64 ºC since the amplifications of wild-type template using mutant-FP315
or mutant template using wild-type FP were negligible (test-t, wild-type vs. background316
p=0.06 and mutant vs. background p=0.07). Thus the experimental results agreed with317
the predicted annealing temperature calculated from the in-silico parameters (63.5 -318
66.1 ºC).319
The following experiments studied the discrimination capability between primers sets320
for the same SNP. Single assays were performed for the specific amplification of each321
target allele using the tested primers. PCR product formation was determined from the322
end-point fluorescence measurements of PCR products and confirmed by gel323
electrophoresis. All the proposed sets showed correct discrimination between the wild-324
type and mutant templates for both reaction mixtures. A multi-factor variance analysis325
was applied to the fluorescence intensities measured by different sets selected for the326
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same SNP. The signal variability between reactions using different primers/probes was327
comparable to the signal variability between reaction replicates (p-value = 0.82 for328
rs1045642, p-value = 0.22 for rs776746, and p-value = 0.61 for rs1801133). These329
experimental results supported the equivalence between the sets reported for SNP330
genotyping.331
332
Checking designed oligonucleotides for multiplex assays based on common333
probe hybridization334
The method based on AS-PCR combined to common probe hybridization (perfect-335
match region that did not contain the genetic variant) was applied [10]. Although the336
throughput is not high, this approach based on chip hybridization shows several337
advantages against other multiplex methods. For instance, the equivalent assay real338
time PCR involves an expensive thermocycler with a detection system based on four339
fluorophores (3 SNPs and internal control). The list of tested oligonucleotides is340
included in Table SI.7. Wild-type and mutant genotypes were amplified in two triplex341
reactions that contained WT-primers or M-primers. PCR products were incubated on342
microarrays with a specific immobilized probe per gene. Low-stringent conditions (low343
salt content and presence of denaturing agent) were chosen to achieve hybridization in344
short incubation times (60 min) and at low temperature (37 ºC). Therefore, the345
hybridization temperature was 30-31 ºC below the calculated melting temperatures of346
the corresponding probes. In all cases, positive signals were observed according to the347
specific polymorphism in the perfectly matched probes (Figure 2). No cross-348
amplification or cross-hybridization problems were observed. Therefore, specific349
products for both variants of each SNP locus (rs1045642, rs776746 and rs1801133)350
were obtained using the proposed oligonucleotide sets.351
352
Checking designed oligonucleotides for multiplex assays based on universal353
hybridization354
An improved variation of the method reported by Li et al. 2008 [9] was applied. A355
description of the method principle and the list of tested oligonucleotides (primers and356
probes) are included in Table SI.8. The advantages compared to conventional357
hybridization approaches are related to the Zip-codes included in primers and as358
probes. The hybridization conditions can be easily selected improving the working359
range and yielding better assay selectivity and sensitivity. Hexaplex PCR was done to360
simultaneously amplify the specific alleles of the targeted regions (genes ABCB1,361
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MTHFR and CYP3A5). Then the amplification mixture contained the perfectly matched362
and mismatched forward primers with different zip-code tails. The products hybridized363
with the specific zip-code probes were immobilized on the slide surface (polycarbonate364
chip). SNP genotyping was achieved because the hybridization profiles differed365
according to the allelic profile. Under these conditions, the amplification factor was366
(5.00.3)108, which is comparable to a single approach (test-t, p>0.05). The high367
yield, without losing discrimination capability, demonstrated that the selected primer368
sets were compatible for the simultaneous amplification of targeted SNPs.369
Hybridization assays were also performed from the PCR products of the homozygote370
mutant, the homozygote wild-type or the heterozygote individuals for three studied371
SNPs. First, the cross-hybridization between the single PCR products and mismatched372
probes was not observed because positive results were obtained for specific probes373
and negative results for the other probes.374
Figure 3 shows an example of the optical signals recorded for a patient with a known375
genotype. As we can see, positive and negative controls provided detectable and376
background responses, respectively. High-intensity positive spots were observed in the377
corresponding probes according to the specific polymorphism.378
The following experiments focused on evaluating the zip-codes provided by the379
proposed workflow under the optimized experimental conditions. Genotyping was380
achieved independently of the used zip-codes because the statistical analysis381
concluded that array signals were comparable (analysis of variance, p>0.5). Therefore,382
the results demonstrated that the oligonucleotides sets with similar design parameters383




The multiplex approach based on universal hybridization was applied to the genotyping388
of the targeted SNPs in patient samples to demonstrate the design workflow and the389
method capabilities as a pharmacogenetic tool. The genotyping of three clinically390
relevant SNPs will support administering related drugs, such as cyclosporine,391
tacrolimus or methotrexate.392
The robustness of population assignation was checked evaluating the assay sensitivity393
and the variability in the registered signals. The sensitivity was calculated from394
mixtures of DNA from mutant homozygotes and wild-type homozygotes (4 ng of total395
genomic extract). The percentage of mutant DNA capable to be detected was 2 %.396
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Intra-assay reproducibility, expressed as the relative standard deviation of three397
replicates performed in the same assay, was between 5% (rs180113, wild-type allele)398
and 20% (rs1045642, mutant allele). Inter-assay reproducibility, expressed as the399
relative standard deviation of three replicates performed in different assays, was 15-400
25%. In all cases, the discrimination indexes, calculated from signals of wild-type and401
mutant probes, were enough consistent to score the same genotype. Hence the402
obtained analytical performances demonstrated that the selected set of403
oligonucleotides was suitable for a robust genotyping of the targeted SNPs.404
The patient genotype was assigned according to the discrimination indexes calculated405
for each studied SNP, and three populations were perfectly distinguished. Figure 4406
shows the values calculated for the different patient groups (wild-type homozygotes,407
mutant homozygotes and heterozygotes). The homozygous genotypes led to high408
positive (wild-type) and high negative (mutant) discrimination index. Intermediate409
indexes were calculated for the heterozygous genotypes. The results indicated that410
primers and probes could reliably distinguish between the wild- and the mutant-type411
PCR product and, consequently, different alleles of SNPs could be easily412
discriminated. The individual detected genotypes are summarized in Table SI.9.413
Assigned genotypes were validated by analyzing samples with reference techniques414
(MassArray and Sanger sequencing).415
416
CONCLUSIONS417
One challenge in pharmacogenomics and pharmacogenetics is to implement418
genotyping technologies that integrate conventional properties (i.e. accuracy,419
robustness, with functional properties), such as low-cost or simplicity. One key point is420
adequate oligonucleotide selection. Easy-to-use computational tools allow the421
adaptation of current or innovative technologies to genotype clinically relevant SNPs.422
So the proposed workflow, comprising simple calculations (few minutes analysis),423
allows the design of allele-specific primers to be employed by the end-user. The main424
advantages of the developed algorithm compared to previous software are multiplicity425
and flexibility by incorporating certain restrictions based on stability calculations.426
Moreover, this tool can support different reported AS-PCR methods including detection427
formats from agarose gel electrophoresis to chip hybridization. Particularly, the study428
demonstrates its effectiveness for setting up a versatile method based on the universal429
array format. This strategy is powerful in terms of SNP genotyping capabilities, but is a430
complex approach in oligonucleotide selection terms.431
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The experimental confirmation of in-silico parameters and the genotypes of patients432
reported by a gold-standard platform reinforce the reliability of the developed design433
workflow and the genotyping method to support organ transplantation as a model of434
relevant application of pharmaceutical analysis. The testing assays were performed on435
polycarbonate chips that it is the bulk material used in many low-cost integrated436
devices. This study can support the development of innovative bioanalytical devices437
(static or microfluidics) based on plastic polymers. Furthermore, the method can be438
extended to other target genes, particularly for the third approach (multiplex assays439
based on universal hybridization). The hybridization conditions make substituting or440
incorporating new SNPs simpler as the experimental efforts of the personalized441
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Table 1. Design tasks for the design of AS-PCR oligonucleotide sets and525
correspondence to program modules526
Table 2. Design restrictions applied for the simultaneous genotyping of rs1045642,527
rs776746, and rs1801133528




Figure 1. Relative fluorescent signal for products obtained from different primer533
sets in function of template (polymorphism rs1801133) and annealing534
temperatures during PCR thermocycling: (a) Single assays using wild-type535
forward primers. (b) Single assays using mutant forward primers536
Figure 2. Multiplex assays based on AS-PCR and microarray detection using537
common probe hybridization (a) Scheme of genotyping method using WT-538
primer (left: amplification, right: hybridization). (b) Scheme of genotyping539
method using M-primer (left: amplification, right: hybridization). (c) Signal-to-540
noise ratios (SNR) of microarray spots from different primer sets. WT: wild-type,541
M: mutant.542
Figure 3. Multiplex assays based on AS-PCR and universal microarray detection.543
(a) Scheme of genotyping method (left: amplification, right: zip-code544
hybridization). (b) Microarray layout. Probes: 1= rs1045642 (WT), 2= rs1045642545
(M), 3= rs776746 (WT), 4= rs776746 (M), 5= rs1801133 (WT), 6= rs1801133546
(M), 7=positive control, 8=negative control. (c) Image for a sample with547
genotypes CT, AG, and CC for rs1045642, rs776746, and rs1801133,548
respectively. WT: wild-type, M: mutant.549
Figure 4. Discrimination index for patient groups according to rs1045642 (a),550
rs776746 (b), and rs1801133 (c).551
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Table 1
STEP DESCRIPTION MODULE IN MULTI-SNP PROGRAM
Step 1: Define input variables INPUT





Objective: Input interface to user
Step 2: Generation of pre-candidate primers SINGLE SELECTION
List of all possible sequences for both strands based
on primer length and SNP distance restrictions
Objective: Selection of FP-allele 1, FP-allele
2, and RP fulfilling primer restrictions
Step 3: Application of single primer restrictions
Elimination of sets according to the values of %GC,
melting temperature, self-annealing and folding
Step 4: Application of product restrictions
Elimination of sets according to hairpin formation
compared to duplex structure (double-strand product)
Step 5: Application of multiplex primer
restrictions
MULTIPLEX SELECTION
Elimination of sets with cross-hybridization (primers to
other templates)
Elimination of sets of inadequate product size
Objective: Selection of sets for the
simultaneous amplification of several genes
Step 6: Search of zip-codes (optional) ZIP-CODES SELECTION
Obtain all combinations of FP-zip-codes
Elimination of sets according to self-annealing and
product/primer annealing values
Objective: Selection of zip-codes probes
fulfilling restrictions
Step 7: Estimation of in-silico PCR conditions OUTPUT
Calculation of annealing temperature for PCR
thermocycling
Objective: Output interface to user
FP: forward primer, RP: reverse primer
19
Table 2
Parameter Studied values Selected values
Forward primer Length interval 17 – 25 mer 17 – 25 mer
%GC interval 35 – 65 % 35 – 65 %
Tm interval 50 – 70 ºC 58 – 62 ºC
Self-annealing Up to 10 nt  8 nt
Tf threshold Up to 65 ºC  50 ºC
Reverse primer Length interval 17 – 25 mer 19 – 22 mer
Distance to SNP Up to 150 bp 70 – 125 bp
%GC interval 35 – 65 % 40 – 60 %
Tm interval 50 – 70 ºC 58 – 62 ºC
Self-annealing Up to 10 nt  8 nt
Tf threshold Up to 65 ºC  50 ºC
Products Tm differences Up to 30 ºC  20 ºC
Tf threshold Up to 65 ºC  50 ºC
Cross-annealing Up to 60 ºC  45 ºC
Size differences
(WT and M products)
Up to 3 bp  1 bp
Size differences
(target products)
Up to 20 bp  10 bp
Zip-code length 20 – 30 mer 20 mer
Tm: melting temperature, Tf: folding temperature calculated for [Na+] = 50 mM
Table 3
MODULE Primer 3 Plus WASP Multi-SNP
Objective General ASA ASA
Support Web pages Web pages Excel
Allelic primers No Yes Yes
Primer constraints Flexible Flexible Flexible
Output: set number Low Low High
Multiplex capability No No Yes
Array module No No Yes
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